AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

PTPI · NASDAQ · Drug Manufacturers - Specialty & Generic

Petros Pharmaceuticals (PTPI)

Builds SaaS and SaMD tools for prescription-to-OTC drug switches.

$0.0047

At close−0.00 (−6.00%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Insiders6 holders · as of Jun 25, 2026	35.33%	14.97M shares
Strategic holders1 holder · as of Feb 17, 2026	10.38%	4.40M shares
Otherremainder	54.29%	23.00M shares

42.37M company shares as of Sep 3, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Joshua SilvermanInsiderdirector	20.75%	8.79M	Form 4filed Jun 5, 2026 ↗
Iroquois Capital Management, LLCStrategic	10.38%	4.40M	13Gfiled Feb 17, 2026 ↗
Bruce BernsteinInsiderdirector	8.88%	3.76M	Form 4filed Jun 5, 2026 ↗
Fady BoctorInsiderofficer: See Remarks	2.11%	894,986	Form 4filed Jun 5, 2026 ↗
Wayne Remell WalkerInsiderdirector	2.08%	881,333	Form 4filed Jun 8, 2026 ↗
Robert WeinsteinInsiderofficer: Chief Accounting Officer	1.50%	636,004	Form 4filed Jun 25, 2026 ↗
Mitchell ArnoldInsiderofficer: See Remarks	0.01%	6,000	Form 4filed Feb 21, 2025 ↗
Ayrton Capital LLCInstitution	—6.20% of class, as filed	—	13Gfiled Feb 13, 2025 ↗
Daniel B. AsherInsider	—7.20% of class, as filed	—	13G/Afiled Feb 11, 2022 ↗
George W. HaywoodInsider	—7.60% of class, as filed	—	13Gfiled Oct 27, 2021 ↗
John D. Shulman¹Insiderdirector, 10 percent owner	0.05%	22,814	Form 4filed Jan 3, 2022 ↗
Greg Bradley²Insiderdirector	0.00%	333	Form 4filed Apr 28, 2023 ↗
Keith Lavan³Insiderofficer: Chief Financial Officer	0.00%	4	Form 4filed Dec 3, 2020 ↗
Andrew Gesek³Insiderofficer: President, Timm Medical	0.00%	0	Form 4filed Dec 3, 2020 ↗

Last filed Jan 3, 2022; leaving the company requires no filing. Not in the bar.
Last filed Apr 28, 2023; leaving the company requires no filing. Not in the bar.
Last filed Dec 3, 2020; leaving the company requires no filing. Not in the bar.

13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F

No 13F holders on record.

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Iroquois Capital Management, LLC	9.99%	4.40M	13G	Feb 17, 2026 ↗
Ayrton Capital LLC	6.20%		13G	Feb 13, 2025 ↗

Petros Pharmaceuticals (PTPI)

Breakdown13F · 13D/G · Form 4

Top shareholders13F · 13D/G · Form 4

Institutions13F

Ownership statements13D/G · 5% or more, as filed

Insider tradesForm 4

Latest trades

CongressHouse and Senate disclosures